Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer

Overview

Journal Noncoding RNA

Date 2023 Mar 24

PMID 36960964

Authors

Yanyan Wang

Jing Zeng

Weidong Chen

Jiangao Fan

Phillip B Hylemon

Huiping Zhou

Affiliations

Soon will be listed here.

Abstract

Liver cancer is the second leading cause of cancer-related death globally, with limited treatment options. Recent studies have demonstrated the critical role of long noncoding RNAs (lncRNAs) in the pathogenesis of liver cancers. Of note, mounting evidence has shown that lncRNA H19, an endogenous noncoding single-stranded RNA, functions as an oncogene in the development and progression of liver cancer, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), the two most prevalent primary liver tumors in adults. H19 can affect many critical biological processes, including the cell proliferation, apoptosis, invasion, and metastasis of liver cancer by its function on epigenetic modification, H19/miR-675 axis, miRNAs sponge, drug resistance, and its regulation of downstream pathways. In this review, we will focus on the most relevant molecular mechanisms of action and regulation of H19 in the development and pathophysiology of HCC and CCA. This review aims to provide valuable perspectives and translational applications of H19 as a potential diagnostic marker and therapeutic target for liver cancer disease.

Citing Articles

Mir-483-5p-mediated activating of IGF2/H19 enhancer up-regulates IGF2/H19 expression via chromatin loops to promote the malignant progression of hepatocellular carcinoma.

Chen W, Wu C, Li Y, Wang T, Huang M, Wang M Mol Cancer. 2025; 24(1):10.

PMID: 39799319 PMC: 11724483. DOI: 10.1186/s12943-024-02204-7.

New Relevant Evidence in Cholangiocarcinoma Biology and Characterization.

Porro N, Spinola-Lasso E, Pastore M, Caligiuri A, Di Tommaso L, Marra F Cancers (Basel). 2025; 16(24.

PMID: 39766138 PMC: 11674836. DOI: 10.3390/cancers16244239.

The role and function of lncRNA in ageing-associated liver diseases.

Zarandi P, Ghiasi M, Heiat M RNA Biol. 2024; 22(1):1-8.

PMID: 39697114 PMC: 11660375. DOI: 10.1080/15476286.2024.2440678.

Deciphering the role of LncRNA in alcoholic liver disease: Mechanisms and therapeutic potential.

Zhang L, Wang R, Nan Y, Kong L Medicine (Baltimore). 2024; 103(45):e40378.

PMID: 39533619 PMC: 11557020. DOI: 10.1097/MD.0000000000040378.

Up-regulation of long non-coding RNA H19 ameliorates renal tubulointerstitial fibrosis by reducing lipid deposition and inflammatory response through regulation of the microRNA-130a-3p/long-chain acyl-CoA synthetase 1 axis.

Jiang Y, Ma F, Wang J, Chen X, Xue L, Chen X Noncoding RNA Res. 2024; 9(4):1120-1132.

PMID: 39022687 PMC: 11254502. DOI: 10.1016/j.ncrna.2024.05.002.

References

Zhang L, Yang Z, Huang W, Wu J . H19 potentiates let-7 family expression through reducing PTBP1 binding to their precursors in cholestasis. Cell Death Dis. 2019; 10(3):168. PMC: 6379488. DOI: 10.1038/s41419-019-1423-6. View

Shermane Lim Y, Xiang X, Garg M, Le M, Wong A, Wang L . The double-edged sword of H19 lncRNA: Insights into cancer therapy. Cancer Lett. 2020; 500:253-262. DOI: 10.1016/j.canlet.2020.11.006. View

Liu Y, Xu L, Lu B, Zhao M, Li L, Sun W . LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling. Mol Immunol. 2019; 116:18-28. DOI: 10.1016/j.molimm.2019.09.006. View

Wang Y, Tai Y, Way G, Zeng J, Zhao D, Su L . RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression. Cell Biosci. 2022; 12(1):172. PMC: 9558407. DOI: 10.1186/s13578-022-00910-7. View

Li C, Li Y, Wang Y, Sun L . The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma. Cell Physiol Biochem. 2018; 50(1):196-213. DOI: 10.1159/000493968. View

Wei L, Li L, Lu C, Liu J, Chen Y, Wu H . Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1. J Cell Physiol. 2018; 234(4):5153-5162. DOI: 10.1002/jcp.27319. View

Cabiati M, Salvadori C, Basta G, Del Turco S, Aretini P, Cecchettini A . miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles. Clin Exp Med. 2021; 22(2):245-255. DOI: 10.1007/s10238-021-00744-6. View

Huang Z, Chu L, Liang J, Tan X, Wang Y, Wen J . H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen-Activated Protein Kinase-Dependent Manner and Sponging microRNA 200b-3p. Hepatology. 2021; 74(1):214-232. DOI: 10.1002/hep.31673. View

Esposti D, Hernandez-Vargas H, Voegele C, Fernandez-Jimenez N, Forey N, Bancel B . Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing. Oncotarget. 2016; 7(22):31862-77. PMC: 5077982. DOI: 10.18632/oncotarget.7364. View

10.

Liang W, Fu W, Wong C, Wang Y, Wang W, Hu G . The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015; 6(26):22513-25. PMC: 4673179. DOI: 10.18632/oncotarget.4154. View

11.

Liu C, Chen Z, Fang J, Xu A, Zhang W, Wang Z . H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation. Tumour Biol. 2015; 37(1):263-70. PMC: 4841850. DOI: 10.1007/s13277-015-3779-2. View

12.

Braghini M, Lo Re O, Romito I, Fernandez-Barrena M, Barbaro B, Pomella S . Epigenetic remodelling in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2022; 41(1):107. PMC: 8943959. DOI: 10.1186/s13046-022-02297-2. View

13.

Hou J, He M, Chen Q, Liang S . LncRNA H19 acts as miR-301a-3p sponge to alleviate lung injury in mice with sepsis by regulating Adcy1. Immunopharmacol Immunotoxicol. 2022; 44(4):565-573. DOI: 10.1080/08923973.2022.2067045. View

14.

Cui C, Li Z, Wu D . The long non-coding RNA H19 induces hypoxia/reoxygenation injury by up-regulating autophagy in the hepatoma carcinoma cells. Biol Res. 2019; 52(1):32. PMC: 6567522. DOI: 10.1186/s40659-019-0239-2. View

15.

Li H, Li J, Jia S, Wu M, An J, Zheng Q . miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer. Oncotarget. 2015; 6(31):31958-84. PMC: 4741653. DOI: 10.18632/oncotarget.5579. View

16.

Beylerli O, Gareev I, Sufianov A, Ilyasova T, Guang Y . Long noncoding RNAs as promising biomarkers in cancer. Noncoding RNA Res. 2022; 7(2):66-70. PMC: 8891810. DOI: 10.1016/j.ncrna.2022.02.004. View

17.

Li X, Liu R, Huang Z, Gurley E, Wang X, Wang J . Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology. 2018; 68(2):599-615. PMC: 6085159. DOI: 10.1002/hep.29838. View

18.

Xu Y, Liu Y, Li Z, Li H, Li X, Yan L . Long non‑coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR‑675. Oncol Rep. 2020; 44(1):165-173. PMC: 7251775. DOI: 10.3892/or.2020.7608. View

19.

Ma H, Yuan L, Li W, Xu K, Yang L . The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1. J Cell Biochem. 2018; 119(10):8325-8335. DOI: 10.1002/jcb.26883. View

20.

Pan F, Zheng Y, Shi C, Zhang F, Zhang J, Fu W . H19-Wnt/β-catenin regulatory axis mediates the suppressive effects of apigenin on tumor growth in hepatocellular carcinoma. Eur J Pharmacol. 2020; 893:173810. DOI: 10.1016/j.ejphar.2020.173810. View